{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:10:58Z","timestamp":1788491458189,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.phrs.2020.104871","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T02:49:42Z","timestamp":1589251782000},"page":"104871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3"],"prefix":"10.1016","volume":"158","author":[{"given":"Linlin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2020.104871_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argiles","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2020.104871_bib0010","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.phrs.2020.104871_bib0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2020.104871_bib0020","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2020.104871_bib0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2020.104871_bib0030","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/jcsm.12233","article-title":"Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia","volume":"8","author":"Bowen","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.phrs.2020.104871_bib0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jcsm.12295","article-title":"A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women","volume":"9","author":"Wright","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.phrs.2020.104871_bib0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ctrv.2018.10.002","article-title":"Cancer cachexia and myopenia - Update on management strategies and the direction of future research for optimizing body composition in cancer - A narrative review","volume":"70","author":"Pring","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phrs.2020.104871_bib0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/13543784.2019.1646727","article-title":"Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials","volume":"28","author":"Molfino","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.phrs.2020.104871_bib0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBPdelta to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2020.104871_bib0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.15252\/emmm.201607052","article-title":"STAT3 promotes IFNgamma\/TNFalpha-induced muscle wasting in an NF-kappaB-dependent and IL-6-independent manner","volume":"9","author":"Ma","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2020.104871_bib0060","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2020.104871_bib0065","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2020.104871_bib0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2020.104871_bib0075","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3945\/ajcn.113.058388","article-title":"Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia","volume":"98","author":"Op den Kamp","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2020.104871_bib0080","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1128\/MCB.23.20.7230-7242.2003","article-title":"Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis","volume":"23","author":"Rebbapragada","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2020.104871_bib0085","first-page":"E5266","article-title":"Specific targeting of TGF-beta family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2020.104871_bib0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2020.104871_bib0095","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","article-title":"PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription","volume":"103","author":"Sandri","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2020.104871_bib0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2020.104871_bib0105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/intimm\/dxr077","article-title":"IL-1beta and TNFalpha-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis","volume":"23","author":"Mori","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.phrs.2020.104871_bib0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jcsm.12031","article-title":"Activin-betaC modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways","volume":"6","author":"Marino","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.phrs.2020.104871_bib0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.freeradbiomed.2015.12.031","article-title":"The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass","volume":"98","author":"Rom","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2020.104871_bib0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semcancer.2016.01.002","article-title":"F-BOX proteins in cancer cachexia and muscle wasting: emerging regulators and therapeutic opportunities","volume":"36","author":"Sukari","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.phrs.2020.104871_bib0125","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.phrs.2020.104871_bib0130","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1111\/bph.14424","article-title":"Activating the pregnane X receptor by imperatorin attenuates dextran sulphate sodium-induced colitis in mice","volume":"175","author":"Liu","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2020.104871_bib0135","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1039\/C7FO01748K","article-title":"Apoptosis effects of imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial\/caspase-mediated pathways","volume":"9","author":"Zhai","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2020.104871_bib0140","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/acs.jnatprod.9b00145","article-title":"Anti-inflammatory property of imperatorin on alveolar macrophages and inflammatory lung injury","volume":"82","author":"Li","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2020.104871_bib0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.canlet.2014.03.017","article-title":"Imperatorin induces Mcl-1 degradation to cooperatively trigger Bax translocation and Bak activation to suppress drug-resistant human hepatoma","volume":"348","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2020.104871_bib0150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2015.12.019","article-title":"Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice","volume":"91","author":"Assi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2020.104871_bib0155","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.phymed.2013.04.020","article-title":"Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma","volume":"20","author":"Yang","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2020.104871_bib0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jep.2017.03.033","article-title":"Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1alpha via the mTOR\/p70S6K\/4E-BP1 and MAPK pathways","volume":"203","author":"Mi","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2020.104871_bib0165","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1021\/acs.analchem.8b01103","article-title":"Biosensor-based active ingredients recognition system for screening STAT3 ligands from medical herbs","volume":"90","author":"Chen","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.phrs.2020.104871_bib0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/28101","article-title":"Three-dimensional structure of the Stat3beta homodimer bound to DNA","volume":"394","author":"Becker","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2020.104871_bib0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2015.09.001","article-title":"Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes","volume":"54","author":"Kazemi-Bajestani","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2020.104871_bib0180","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jcsm.12199","article-title":"Muscle mass as a target to reduce fatigue in patients with advanced cancer","volume":"8","author":"Neefjes","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.phrs.2020.104871_bib0185","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1158\/1078-0432.CCR-16-0495","article-title":"Molecular pathways: cachexia signaling-a targeted approach to Cancer treatment","volume":"22","author":"Miyamoto","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2020.104871_bib0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543776.2011.539205","article-title":"Signal transducer and activator of transcription 3 inhibitors: a patent review","volume":"21","author":"Page","year":"2011","journal-title":"Expert Opin. Ther. Pat."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820311798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820311798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:10:52Z","timestamp":1760911852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820311798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"alternative-id":["S1043661820311798"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104871","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104871"}}